Unjha Formulations Limited is an India-based company, which is engaged in manufacturing and exporting of isabgol (psyllium) ayurvedic products. The Company is engaged in service to the isabgol (psyllium) ayurvedic formulation profession. It also manufactures all kinds of small volume ayurvedic isabgol (psyllium) powder and is tested at its plant with a modern and well equipped physico chemical and micro biological quality control laboratory. The Company’s Anchor Sat-Isabgol is available in 50 grams (gms), 100 gm, 200 gm, and 400 gm. Its isabgo husk formulation is available in the elaichi flavor. The Company’s Fibron is available in 100 gms and 300 gms. Its Isabgol Poder is available in the orange flavor. Its Fibron SF (sugar-free) is available in 100 gm and 300 gm.
UNJHA FORMULATIONS LTD. Financial Highlights
- Revenue: UNJHA FORMULATIONS LTD. reported revenue of ₹15.75 crore in FY26 vs ₹13.98 crore in FY25. It showed an increase of 12.66% on a yearly basis.
- Operating Profit: UNJHA FORMULATIONS LTD. reported an operating profit of ₹0.95 crore in FY26 vs ₹0.52 crore in FY25. It showed an increase of 82.69% on a year-on-year basis.
- Net Profit: UNJHA FORMULATIONS LTD. reported a net profit of ₹0.70 crore in FY26 vs ₹0.41 crore in FY25. It showed an increase of 70.73% on a yearly basis.
UNJHA FORMULATIONS LTD. Quarterly Result Highlights
- UNJHA FORMULATIONS LTD. reported revenue of ₹3.33 crore in Mar 2026, compared with ₹4.44 crore in Dec 2025, representing a decrease of 25.00% on a quarter-on-quarter (QoQ) basis.
- UNJHA FORMULATIONS LTD. reported an operating loss of ₹0.49 crore in Mar 2026, compared with ₹0.24 crore in Dec 2025, representing a decrease of 304.17% on a quarter-on-quarter (QoQ) basis.
- UNJHA FORMULATIONS LTD. reported a loss of ₹0.74 crore in Mar 2026, compared with ₹0.24 crore in Dec 2025, reflecting a decrease of 408.33% on a QoQ basis.
- The earnings per share (EPS) of UNJHA FORMULATIONS LTD. stood at ₹0.91 during Mar 2026.